PMVP Insider Trading

Insider Ownership Percentage: 7.60%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $15,163.50

PMV Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at PMV Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$400k-$200k$0$200k$400kTotal Insider BuyingTotal Insider Selling

PMV Pharmaceuticals Share Price & Price History

Current Price: $1.02
Price Change: Price Increase of +0.02 (2.00%)
As of 04/17/2025 05:00 PM ET

This chart shows the closing price history over time for PMVP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMarApr$1.02Closing price on 04/19/25:

PMV Pharmaceuticals Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for PMV Pharmaceuticals (NASDAQ:PMVP)

90.20% of PMV Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PMVP by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$0bought$39ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$2M$0$2MTotal InflowsTotal Outflows
PMV Pharmaceuticals logo
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is PC14586, a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.
Read More on PMV Pharmaceuticals

Today's Range

Now: $1.02
Low: $0.95
High: $1.04

50 Day Range

MA: $1.19
Low: $0.87
High: $1.44

52 Week Range

Now: $1.02
Low: $0.82
High: $2.26

Volume

89,356 shs

Average Volume

257,428 shs

Market Capitalization

$52.97 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.49

Who are the company insiders with the largest holdings of PMV Pharmaceuticals?

PMV Pharmaceuticals' top insider investors include:
  1. Deepika Jalota (Insider)
  2. Michael Carulli (CFO)
  3. Orbimed Advisors Llc (Major Shareholder)
Learn More about top insider investors at PMV Pharmaceuticals.

Who are the major institutional investors of PMV Pharmaceuticals?

PMV Pharmaceuticals' top institutional shareholders include:
  1. Assenagon Asset Management S.A. — 0.22%
Learn More about top institutional investors of PMV Pharmaceuticals stock.

Which major investors are selling PMV Pharmaceuticals stock?

Within the previous quarter, PMVP stock was sold by these institutional investors:
  1. Assenagon Asset Management S.A.
Within the last year, company insiders that have sold PMV Pharmaceuticals company stock include:
  1. Deepika Jalota (Insider)
  2. Michael Carulli (CFO)
Learn More investors selling PMV Pharmaceuticals stock.